CVS Caremark (CVS)

Must be logged in to add this company to your watchlist.

Click here to login.

CVS - NYSE - 3/12/2010 8:00 PM

34.63
Change -0.03
% Change -0.09%
Market Cap Revenue Growth Profit Margin Cash
$48.85B 6.96% 4.06% $1.09B
78 / 4569 1409 / 4568 2214 / 4566 415 / 4096

For the December 2009 quarter, CVS Caremark spent 0% of gross profits on R&D and 65.96% on SGA expenses. Revenues rose 6.96% year-over-year to $25.82B. The company is trading at 13.58 times earnings(PE) and 0.49 times revenue(PSR). At the end of December 2009, CVS Caremark had $1.09B in cash on hand and $8.76B in long-term debt. On 02/08/2010, CVS Caremark reported net income of $1.05B, with diluted earnings per share of $0.74.

Valuation

Price

Current stock price.

PE Ratio: 13.58

Price paid for a share relative to the annual income earned.

Price to Sales Ratio: 0.49

Market cap divided by revenue.

Growth & Profitability

Revenue Growth: 6.96%

Revenue growth year-over-year.

Earnings per Share: $0.74

Portion of profit allocated to each outstanding share of common stock.

Profit Margin: 4.06%

Margin made on every dollar of revenue.

Fundamentals

Income Statement

Summary of revenues, expenses & profits.

Balance Sheet

Company's assets, liabilities & shareholders' equity at a specific point in time.

Cash Flow

Cash inflows arise from one of three activities - operations, financing, or investing.